Study investigated prognostic impact of myc rearrangement in patients with DLBCL.
Home / Resource Library / A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma
Study investigated prognostic impact of myc rearrangement in patients with DLBCL.